Frances R. Levin

13.8k total citations · 1 hit paper
272 papers, 8.7k citations indexed

About

Frances R. Levin is a scholar working on Epidemiology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Frances R. Levin has authored 272 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Epidemiology, 97 papers in Pharmacology and 95 papers in Psychiatry and Mental health. Recurrent topics in Frances R. Levin's work include Substance Abuse Treatment and Outcomes (93 papers), Neurotransmitter Receptor Influence on Behavior (75 papers) and Attention Deficit Hyperactivity Disorder (75 papers). Frances R. Levin is often cited by papers focused on Substance Abuse Treatment and Outcomes (93 papers), Neurotransmitter Receptor Influence on Behavior (75 papers) and Attention Deficit Hyperactivity Disorder (75 papers). Frances R. Levin collaborates with scholars based in United States, United Kingdom and Netherlands. Frances R. Levin's co-authors include Edward V. Nunes, Suzette M. Evans, John J. Mariani, Daniel J. Brooks, Adam Bisaga, Elias Dakwar, Richard W. Foltin, Vito Agosti, Martina Pavlicová and Herbert D. Kleber and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Frances R. Levin

262 papers receiving 8.3k citations

Hit Papers

Development of a Cascade of Care for responding to the op... 2019 2026 2021 2023 2019 50 100 150 200

Peers

Frances R. Levin
Helen M. Pettinati United States
Herbert D. Kleber United States
Ashwin A. Patkar United States
John Rotrosen United States
Raymond F. Anton United States
Alan J. Budney United States
Frances R. Levin
Citations per year, relative to Frances R. Levin Frances R. Levin (= 1×) peers Tony P. George

Countries citing papers authored by Frances R. Levin

Since Specialization
Citations

This map shows the geographic impact of Frances R. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances R. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances R. Levin more than expected).

Fields of papers citing papers by Frances R. Levin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances R. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances R. Levin. The network helps show where Frances R. Levin may publish in the future.

Co-authorship network of co-authors of Frances R. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Frances R. Levin. A scholar is included among the top collaborators of Frances R. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances R. Levin. Frances R. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, Timothy D., et al.. (2025). Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York. American Journal of Preventive Medicine. 69(5). 108000–108000. 1 indexed citations
2.
Becker, Timothy D., et al.. (2025). Cannabis Access by Retailer Type in New York. PEDIATRICS. 155(3). 2 indexed citations
3.
Xu, Kevin Y., Caitlin E. Martin, Hendrée E. Jones, et al.. (2024). Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder. Nature Mental Health. 2(7). 801–808. 2 indexed citations
4.
Sung, Minhee, Anne C. Black, Brandy F. Henry, et al.. (2024). Clinician and Practice Characteristics Associated With Support of Office-based Methadone: Findings From a National Survey. Journal of Addiction Medicine. 19(2). 150–156.
5.
Schultebraucks, Katharina, Cale Basaraba, Brandy F. Henry, et al.. (2023). The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study. Molecular Psychiatry. 28(6). 2462–2468. 12 indexed citations
6.
Litwin, Alain H., et al.. (2023). Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial. Journal of Addiction Medicine. 17(4). e232–e239. 9 indexed citations
7.
Olfson, Mark, et al.. (2023). Nondisordered Cannabis Use Among US Adolescents. JAMA Network Open. 6(5). e2311294–e2311294. 21 indexed citations
8.
Sung, Minhee, Anne C. Black, Brandy F. Henry, et al.. (2022). Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of Addiction Medicine. 16(5). 505–513. 6 indexed citations
9.
Arout, Caroline A., Ziva D. Cooper, Stephanie Collins Reed, et al.. (2021). 5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers. Addiction Biology. 26(4). e12993–e12993. 12 indexed citations
10.
Levin, Frances R., John J. Mariani, Martina Pavlicová, et al.. (2021). Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219. 108482–108482. 7 indexed citations
12.
Levin, Frances R., John J. Mariani, C. Jean Choi, et al.. (2021). Non-abstinent treatment outcomes for cannabis use disorder. Drug and Alcohol Dependence. 225. 108765–108765. 10 indexed citations
13.
Brandt, Laura, et al.. (2020). Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction. 116(4). 694–710. 49 indexed citations
14.
Rosenthal, Richard N., Justine W. Welsh, Hilary S. Connery, et al.. (2020). Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry. American Journal on Addictions. 29(5). 401–406. 1 indexed citations
15.
Cunningham, Chinazo O., Joanna L. Starrels, Chenshu Zhang, et al.. (2020). Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain. BMJ Open. 10(12). e043400–e043400. 7 indexed citations
16.
Levin, Frances R., C. Jean Choi, Martina Pavlicová, et al.. (2018). How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug and Alcohol Dependence. 188. 135–140. 19 indexed citations
17.
Nunes, Edward V. & Frances R. Levin. (2008). Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations. Psychiatric Annals. 38(11). 730–738. 14 indexed citations
18.
Levin, Frances R., et al.. (2008). Treating Alcohol Dependence: When and How to Use 4 Medications; Some Help Patients Achieve Abstinence, Whereas Others Assist in Maintaining Sobriety. Current psychiatry. 7(2). 25. 1 indexed citations
19.
Agosti, Vito & Frances R. Levin. (2006). The Effects of Alcohol and Drug Dependence on the Course of Depression. American Journal on Addictions. 15(1). 71–75. 21 indexed citations
20.
Hien, Denise A. & Frances R. Levin. (1994). Trauma and Trauma-Related Disorders for Women on Methadone: Prevalence and Treatmemt Considerations. Journal of Psychoactive Drugs. 26(4). 421–429. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026